Overview
Status
Active
Registry date
2001-08-30
Share capital
39,000.00 PLN
Registered address
Aleja Jana Pawła II 80/5c, 00-175 Warszawa, Poland
Financials
Revenue history (in k)
Filing timeliness
5 of 6 financial statements were filed late (the longest delay 1609 days for 2020).
- 202512/03/2026
- 202403/04/2026
- 202303/04/2026
- 202203/04/2026
- 202103/04/2026
- 202012/03/2026
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 24.84kMedianUSD 23.71kAverageUSD 208.45k
Net profit
This companyUSD 2.97kMedianUSD 0.06AverageUSD 9.04k
Operating costs
This companyUSD 21.60kMedianUSD 27.06kAverageUSD 200.38k
Assets
This companyUSD 20.53kMedianUSD 16.02kAverageUSD 151.84k
Industry
Authorized Representatives
Enkhbold Tsendjav – President of the Management Board
Gerel Raidan – V-Ce Prezes Zarządu
Manner of representation
Each member of the management board independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Gerel Raidan | – | $5,267.42 | 50% |
Enkhbold Tsendjavage 54 | 39 | $5,267.42 | 50% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
6 public aid cases recorded, with a total value of $7,751.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jul 20, 2021 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,294$1,294 | Prezydent Miasta Stołecznego Warszawy | |
| Jun 25, 2021 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,294$1,294 | Prezydent Miasta Stołecznego Warszawy | |
| Jun 10, 2021 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,294$1,294 | Prezydent Miasta Stołecznego Warszawy |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| SEK Centrumsp. z o.o. | $131,667.77 | sekcentrum.pl | ||
| Naturomedicasp. z o.o. | $22,587.37 | noctua24.pl | ||
| Telepolandsp. z o.o. | $6,341.95 | zwrotpieniedzy.pl | ||
| Podox Podologiasp. z o.o. | – | podox.net | ||
| Bioporadniasp. z o.o. | – | bioporadnia.pl | ||
| Instytut Zdrowia Im. Ewy i Sobiesława Zasady Sofrasp. j. | – | sofra.com.pl | ||
| Ackermann Clinicsp. z o.o. | – | ackermanncare.com | ||
| Afirma Bio i Holisp. z o.o. | – | bioiholi.pl | ||
| Holistic Bloomsp. z o.o. | – | holisticbloom.pl | ||
| Odnovasp. z o.o. | – | odnova.bio |
Change history
| Date | Event | |
|---|---|---|
| 2026-04-23 | Address change (Bielańska 9/8, 00-086, Warszawa → Aleja Jana Pawła Ii 80/5c, 00-175, Warszawa) | |
| 2002-04-09 | Share capital increase (7,800.00 PLN → 39,000.00 PLN) | |
| 2001-08-30 | Entered in the register |
FAQ
The main business activity of Gerbay focuses on traditional, complementary and alternative medicine activities.
The company was registered in the Polish National Court Register (KRS) on August 30, 2001.
The headquarters is located at: Aleja Jana Pawła Ii 80, 00-175 Warszawa.
The share capital of the company is PLN 39,000 (approx. $10,535).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
In 2025, the company generated total revenue of $24,837, representing a decrease of 45.7% compared to 2024.
Yes, the company recorded a net profit of $2,972 in 2025, representing a multi-fold increase compared to 2024.
The largest operating cost category falls under employee remuneration. This category amounted to $17,870 in 2025, representing 83% of all operating expenses.
Last updated: 2026-06-12